Semantic Scholar uses AI to extract papers important to this topic.
BackgroundAlthough the number of antihyperglycemic agents has expanded significantly, sulfonylureas (in particular gliclazide… Expand Background and objectiveGliclazide is a drug commonly used in type 2 diabetes mellitus. Recently, gliclazide has shown desirable… Expand A modified release gliclazide 60 mg tablet using Methocel® K100 Premium LV DC2 as a
drug retaining polymer was prepared by… Expand Objective of this study was to formulate directly compressible fast dissolving tablets of Gliclazide with sufficient mechanical… Expand Abstract▴ Gliclazide modified release (MR) is a new formulation of the drug gliclazide and is given once daily. The hydrophilic… Expand OBJECTIVE
To compare the efficacy and tolerability of metformin, rosiglitazone and gliclazide MR as monotherapy and in… Expand Background Progressive β‐cell failure is a characteristic feature of type 2 diabetes; consequently, β‐cell secretagogues are… Expand